首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Bendamustine/polatuzumab-vedotin/rituximabVarious toxicities and compassionate use: 7 case reports
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2022年
/ 1927卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-022-24866-1
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:130 / 130
相关论文
共 50 条
[1]
Bendamustine/polatuzumab-vedotin/rituximabVarious toxicities: 5 case reports
[J].
Reactions Weekly,
2022,
1889
(1)
: 84
-
84
[2]
Bendamustine/polatuzumab-vedotin/rituximabVarious toxicities: 3 case reports
[J].
Reactions Weekly,
2022,
1893
(1)
: 73
-
73
[3]
Bendamustine/polatuzumab vedotin/rituximabVarious toxicities: 5 case reports
[J].
Reactions Weekly,
2022,
1914
(1)
: 125
-
125
[4]
Bendamustine/Polatuzumab-vedotin/RituximabLack of efficacy
[J].
Reactions Weekly,
2024,
2009
(1)
: 113
-
113
[5]
Bendamustine/polatuzumab-vedotin/rituximabPeripheral neuropathy and lack of efficacy: 4 case reports
[J].
Reactions Weekly,
2022,
1921
(1)
: 64
-
64
[6]
Bendamustine/polatuzumab-vedotin/rituximabMucormycosis and severe COVID-19: 2 case reports
[J].
Reactions Weekly,
2023,
1941
(1)
: 100
-
100
[7]
Bendamustine/polatuzumab-vedotin/rituximabCytokine release syndrome
[J].
Reactions Weekly,
2024,
1998
(1)
: 114
-
114
[8]
Bendamustine/polatuzumab-vedotin/rituximabLack of efficacy following an off-label use: case report
[J].
Reactions Weekly,
2022,
1935
(1)
: 113
-
113
[9]
Bendamustine/rituximabVarious toxicities: 4 case reports
[J].
Reactions Weekly,
2017,
1665
(1)
: 51
-
51
[10]
Bendamustine/rituximabVarious toxicities: 5 case reports
[J].
Reactions Weekly,
2015,
1547
(1)
: 52
-
52
←
1
2
3
4
5
→